LCN2 and hematologic disorder: In previous studies evaluating the NGAL levels in patients with hematological malignancies, the samples examined were mostly peripheral blood (PB).5, 6, 7 Although a previous study was conducted using human bone marrow (BM) samples, the only disease entity examined in that study was acute myeloid leukemia (AML).9